I am in complete agreement with most posters on this site that are questioning the floundering SP and what appears to be a complete lack of big pharma interest, despite a wealth of positive information (much of which researched and is posted by you, not the company).
Am I missing something here? Is it that our IP is not robust enough to support greater investment?
Cheers
benitec ip
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)